Method for treating histamine H3 receptor-mediated disorders with 2- or 3-aryl substituted imidazo[1,2-a] pyridines
申请人:Ortho-McNeil Pharmaceutical, Inc.
公开号:US06489337B1
公开(公告)日:2002-12-03
The invention features methods of using pharmaceutically-active 2- or 3-aryl substituted imidazopyridines for the treatment of histamine H3 receptor-mediated disorders.
该发明涉及使用具有药理活性的2-或3-芳基取代咪唑吡啶类化合物治疗组胺H3受体介导的疾病的方法。